Nanoparticle-Patterned Multicompartmental Chitosan Capsules for Oral Delivery of Oligonucleotides

Taehyung Kim, Jeong Un Kim, Kyungjik Yang, Keonwook Nam, Deokyeong Choe, Eugene Kim, Il Hwa Hong, Minjung Song, Hyunah Lee, Jiyong Park, Young Hoon Roh

Research output: Contribution to journalArticle

Abstract

Orally administered antisense therapy has been introduced as an effective approach for treating cancer in the gastrointestinal tract. However, its practical application has been limited by the instability of oligonucleotides and their inefficient delivery. To overcome these problems, we synthesized size-dependent, oligonucleotide nanoparticle-patterned chitosan/phytic acid (ODN/CS/PA) capsules with protective shields via a three-step process of self-assembly, nanoparticle encapsulation, and shell formation. The multicompartmental capsule size and oligonucleotide nanoparticle-loading pattern were controlled by applying different potentials during the electrostatic extrusion process used for nanoparticle encapsulation. Over 95% of encapsulated oligonucleotides were protected from nuclease digestion (DNase I) and, depending on their size, showed 40-75% protection against simulated gastric fluid. Their controlled release from capsules correlated with the cellular delivery of released nanoparticles and the inhibition of protein expression in cancer cells. Specifically, large capsules showed approximately 32-fold greater delivery to cancer cells than nonencapsulated nanoparticles. We also confirmed delivery of oligonucleotide nanoparticles to the small intestine and colon of rats following oral administration. These findings demonstrate that the multicompartmental ODN/CS/PA capsules can facilitate efficient oral delivery of oligonucleotides for cancer treatment.

Original languageEnglish
JournalACS Biomaterials Science and Engineering
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Oligonucleotides
Chitosan
Capsules
Nanoparticles
Phytic Acid
Encapsulation
Cells
Oncology
Acids
Deoxyribonuclease I
Self assembly
Extrusion
Rats
Electrostatics
Proteins
Fluids

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Biomedical Engineering

Cite this

Kim, Taehyung ; Kim, Jeong Un ; Yang, Kyungjik ; Nam, Keonwook ; Choe, Deokyeong ; Kim, Eugene ; Hong, Il Hwa ; Song, Minjung ; Lee, Hyunah ; Park, Jiyong ; Roh, Young Hoon. / Nanoparticle-Patterned Multicompartmental Chitosan Capsules for Oral Delivery of Oligonucleotides. In: ACS Biomaterials Science and Engineering. 2018.
@article{8c22559d9d9e420b9e64899eb26917d9,
title = "Nanoparticle-Patterned Multicompartmental Chitosan Capsules for Oral Delivery of Oligonucleotides",
abstract = "Orally administered antisense therapy has been introduced as an effective approach for treating cancer in the gastrointestinal tract. However, its practical application has been limited by the instability of oligonucleotides and their inefficient delivery. To overcome these problems, we synthesized size-dependent, oligonucleotide nanoparticle-patterned chitosan/phytic acid (ODN/CS/PA) capsules with protective shields via a three-step process of self-assembly, nanoparticle encapsulation, and shell formation. The multicompartmental capsule size and oligonucleotide nanoparticle-loading pattern were controlled by applying different potentials during the electrostatic extrusion process used for nanoparticle encapsulation. Over 95{\%} of encapsulated oligonucleotides were protected from nuclease digestion (DNase I) and, depending on their size, showed 40-75{\%} protection against simulated gastric fluid. Their controlled release from capsules correlated with the cellular delivery of released nanoparticles and the inhibition of protein expression in cancer cells. Specifically, large capsules showed approximately 32-fold greater delivery to cancer cells than nonencapsulated nanoparticles. We also confirmed delivery of oligonucleotide nanoparticles to the small intestine and colon of rats following oral administration. These findings demonstrate that the multicompartmental ODN/CS/PA capsules can facilitate efficient oral delivery of oligonucleotides for cancer treatment.",
author = "Taehyung Kim and Kim, {Jeong Un} and Kyungjik Yang and Keonwook Nam and Deokyeong Choe and Eugene Kim and Hong, {Il Hwa} and Minjung Song and Hyunah Lee and Jiyong Park and Roh, {Young Hoon}",
year = "2018",
month = "1",
day = "1",
doi = "10.1021/acsbiomaterials.8b00806",
language = "English",
journal = "ACS Biomaterials Science and Engineering",
issn = "2373-9878",
publisher = "American Chemical Society",

}

Nanoparticle-Patterned Multicompartmental Chitosan Capsules for Oral Delivery of Oligonucleotides. / Kim, Taehyung; Kim, Jeong Un; Yang, Kyungjik; Nam, Keonwook; Choe, Deokyeong; Kim, Eugene; Hong, Il Hwa; Song, Minjung; Lee, Hyunah; Park, Jiyong; Roh, Young Hoon.

In: ACS Biomaterials Science and Engineering, 01.01.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nanoparticle-Patterned Multicompartmental Chitosan Capsules for Oral Delivery of Oligonucleotides

AU - Kim, Taehyung

AU - Kim, Jeong Un

AU - Yang, Kyungjik

AU - Nam, Keonwook

AU - Choe, Deokyeong

AU - Kim, Eugene

AU - Hong, Il Hwa

AU - Song, Minjung

AU - Lee, Hyunah

AU - Park, Jiyong

AU - Roh, Young Hoon

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Orally administered antisense therapy has been introduced as an effective approach for treating cancer in the gastrointestinal tract. However, its practical application has been limited by the instability of oligonucleotides and their inefficient delivery. To overcome these problems, we synthesized size-dependent, oligonucleotide nanoparticle-patterned chitosan/phytic acid (ODN/CS/PA) capsules with protective shields via a three-step process of self-assembly, nanoparticle encapsulation, and shell formation. The multicompartmental capsule size and oligonucleotide nanoparticle-loading pattern were controlled by applying different potentials during the electrostatic extrusion process used for nanoparticle encapsulation. Over 95% of encapsulated oligonucleotides were protected from nuclease digestion (DNase I) and, depending on their size, showed 40-75% protection against simulated gastric fluid. Their controlled release from capsules correlated with the cellular delivery of released nanoparticles and the inhibition of protein expression in cancer cells. Specifically, large capsules showed approximately 32-fold greater delivery to cancer cells than nonencapsulated nanoparticles. We also confirmed delivery of oligonucleotide nanoparticles to the small intestine and colon of rats following oral administration. These findings demonstrate that the multicompartmental ODN/CS/PA capsules can facilitate efficient oral delivery of oligonucleotides for cancer treatment.

AB - Orally administered antisense therapy has been introduced as an effective approach for treating cancer in the gastrointestinal tract. However, its practical application has been limited by the instability of oligonucleotides and their inefficient delivery. To overcome these problems, we synthesized size-dependent, oligonucleotide nanoparticle-patterned chitosan/phytic acid (ODN/CS/PA) capsules with protective shields via a three-step process of self-assembly, nanoparticle encapsulation, and shell formation. The multicompartmental capsule size and oligonucleotide nanoparticle-loading pattern were controlled by applying different potentials during the electrostatic extrusion process used for nanoparticle encapsulation. Over 95% of encapsulated oligonucleotides were protected from nuclease digestion (DNase I) and, depending on their size, showed 40-75% protection against simulated gastric fluid. Their controlled release from capsules correlated with the cellular delivery of released nanoparticles and the inhibition of protein expression in cancer cells. Specifically, large capsules showed approximately 32-fold greater delivery to cancer cells than nonencapsulated nanoparticles. We also confirmed delivery of oligonucleotide nanoparticles to the small intestine and colon of rats following oral administration. These findings demonstrate that the multicompartmental ODN/CS/PA capsules can facilitate efficient oral delivery of oligonucleotides for cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=85058104004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058104004&partnerID=8YFLogxK

U2 - 10.1021/acsbiomaterials.8b00806

DO - 10.1021/acsbiomaterials.8b00806

M3 - Article

JO - ACS Biomaterials Science and Engineering

JF - ACS Biomaterials Science and Engineering

SN - 2373-9878

ER -